一品红：陷5.28亿元知识产权纠纷案被起诉，已聘请律师团队，将积极应诉

Core Viewpoint - Yipinhong Pharmaceutical Group Co., Ltd. is facing a lawsuit from Huiyou International Ltd. regarding intellectual property disputes, with the claimed amount being 528.6 million yuan [2][3] Group 1: Lawsuit Details - The lawsuit was filed in the Guangdong High People's Court, and the case has been accepted but not yet heard [2] - The dispute traces back to a cooperation agreement signed in October 2014, where Yipinhong's subsidiary, Guangzhou Yipinhong Pharmaceutical Co., Ltd., and Huiyou International agreed to establish a joint venture, Guangzhou Pinrui Pharmaceutical Technology Co., Ltd. [2] - The joint venture was established with a cash investment of 10 million yuan, with Yipinhong holding 52% and Huiyou holding 48% [2] Group 2: Claims and Counterclaims - Huiyou International claims that the original valuation of the intellectual property injected into the joint venture was 88 million yuan, leading to a compensation request of 528 million yuan, which is six times the original valuation [3] - The lawsuit requests the defendants to cease infringement on specific patents and to transfer ownership of another patent to Huiyou International [3] Group 3: Company Response - Yipinhong asserts that it has complied with the agreement by paying 15 million yuan in 2015-2016 and denies any breach of contract [4] - The company has engaged a legal team to analyze the lawsuit and believes that the claims made by Huiyou International should be dismissed [4] - Yipinhong emphasizes that the lawsuit will not impact its daily operations or research and development [4] Group 4: Financial Performance - For the first three quarters of 2025, Yipinhong reported revenue of 814 million yuan, a year-on-year decrease of 34.35%, and a net profit of 136 million yuan, with losses narrowing by 44.80% year-on-year [5] - As of the announcement date, Yipinhong and its subsidiaries have other undisclosed litigation matters totaling 5.6312 million yuan, with no claims as a plaintiff [5]